Arome Launches Agentic AI Platform for Fragrance Molecule Discovery and Biosynthesis

STAMFORD, Conn., Oct. 20, 2026 /PRNewswire/ -- Arome today announced the launch of its agentic AI platform for novel fragrance molecule discovery. From an olfactive brief, the platform generates molecular candidates, predicts their likely odor characteristics and identifies potential biosynthetic pathways for production.

Individual aroma molecules can define the character of successful fragrances and become valuable assets for the companies that develop them. The ingredients available to perfumers represent a small fraction of the vast chemical space of potential odorants. Discovering and developing new materials requires extensive research, synthesis and testing.

Arome provides ingredient R&D teams with novel molecular candidates, predicted olfactive profiles and potential biosynthetic production pathways to guide further development.

"A single molecule can define the character of a fragrance and help make it one people love," said Olivia Jezler, co-founder of Arome. "The discovery of new aroma molecules has enormous creative and commercial potential. We built Arome to expand those possibilities while considering how these molecules might be produced from the outset."

Identifying potential biosynthetic pathways may also open new opportunities for more sustainable fragrance ingredient production.

Arome is now available to fragrance ingredient manufacturers and biotechnology companies seeking new approaches to molecular discovery. For inquiries, visit arome.ai.

About Arome

Arome develops agentic AI software for novel fragrance molecule discovery, combining molecular generation, odor prediction and biosynthetic pathway assessment.

SOURCE Arome